FEMALE PELVIC FLOOR DYSFUNCTION FROM THE PERSPECTIVES OF GENETIC STUDIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Currently, despite the growing prevalence of female pelvic floor dysfunction, no consensus exists among researchers regarding its etiology and pathogenesis. There is no doubt, however, that this is a multifactorial disorder with a genetic predisposition. The risk for developing pelvic floor dysfunction is determined by the interaction of multiple additive genetic (mutations and/or polymorphic alleles) and environmental factors. This review of the world literature presents a rationale for searching specific molecular genetic factors shaping the structure of the genetic susceptibility to female pelvic floor dysfunction. The pelvic organ prolapse in women has been found to be associated with the rs1800012 polymorphism of the COL1A1 gene, genotype rs1800255-A/A of COL3A1 gene and the rs2228480 polymorphism of ESR1, although this data still controversial and need to be validated in the independent samples. The systematic accumulation of data, their reproduction in different populations and ethnic groups is necessary to further generalize the evidence on the pathogenesis and the functional significance of each gene variant.

Full Text

Restricted Access

About the authors

L. V Akulenko

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: akular@list.ru
MD, PhD in Medical Sciences, Chair of the department of Medical genetics Moscow, Russia

G. R Kasyan

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: g.kasyan@outlook.com
MD, PhD in Medical Sciences, Professor of the department of Urology Moscow, Russia

Yu. O Kozlova

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: kozlova.julie@gmail.com
MD, PhD in Medical Sciences, Assistant professor of the department of Urology Moscow, Russia

N. V Tupikina

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: tatatu@yandex.ru
MD, PhD in Medical Sciences, Senior Assistant of the department of Urology Moscow, Russia

D. A Vishnevsky

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: dimonvishnevskii050590@yandex.ru
PhD student in Medical Sciences of the department of Urology Moscow, Russia

D. Yu Pushkar

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: pushkardm@mail.ru
MD, PhD in Medical Sciences, Chair of the department of Urology Moscow, Russia

References

  1. Ellerkmann R.M., Cundiff G.W., Melick C.F., Nihira M.A., Leffler K., Bent A.E. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol. 2001;185(6):1332-1337.
  2. Nygaard I., Barber M.D., Burgio K.L., Kenton K., Meikle S., Schaffer J., Spino C., Whitehead W.E., Wu J., Brody D.J; Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008;300:1311-1316.
  3. Haylen B.T., De Ridder D., Freeman R.M., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29: 4-20.
  4. Fritel X., Varnoux N., Zins M., Breart G., Ringa V. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol. 2009;113(3):609-616.
  5. Гвоздев М.Ю., Пушкарь Д.Ю., Тупикина Н.В. Вопросники как инструмент оценки качества жизни пациентки урогинекологического профиля. Российский вестник акушера-гинеколога. 2013;1391:23-30
  6. Adjoussou S.A., Bohoussou E., Bastide S., Letouzey V., Fatton B., de Tayac R. Functional symptoms and associations of women with genital prolapse. Prog Urol. 2014;24(8):511-517.
  7. Burgio K.L., Matthews K.A., Engel B.T. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol 1991;146: 1255-1259.
  8. Lawrence J.M., Lukacz E.S., Nager C.W., Hsu J.W.Y., Luber K.M. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 2008;111:678-685.
  9. Аполихина И.А., Адикян В.М. Эпидемиологические аспекты недержания мочи. Журнал Российского общества акушеров-гинекологов. 2005;1:12
  10. Гвоздев М.Ю., Пушкарь Д.Ю., Касян Г.Р. и др. Недержание мочи при напряжении у пациенток с опущением и выпадением тазовых органов. Эндоскопическая хирургия. 2013;19(4):87-94
  11. Адамян Л.В., Смольнова Т.Ю., Сидоров В.В. Лазерная допплеровская флоуметрия в изучении состояния микроциркуляторного русла у больных с опухолевыми заболеваниями гениталий. Вопросы гинекологии, акушерства и перинатологии. 2006;5:34-39
  12. Краснопольский В.И., Буянова С.Н., Щукина Н.А. и др. Хирургическое лечение больных с опущением и выпадением внутренних половых органов и профилактика опущения купола влагалища после гистерэктомии. Российский вестник акушера-гинеколога. 2006;6(4):66-71
  13. Samuelsson E.C., Victor F.T., Tibblin G., Svardsudd K.F. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am. J. Obstet. Gynecol. 1999;180 (2 Pt l): 299-305.
  14. Deeb M.E., Awwad J., Yeretzian J.S., Kaspar H.G. Prevalence of reproductive tract infections, genital prolapse, and obesity in a rural community in Lebanon. Bull World Health Organ. 2003;81(9):639-645.
  15. Tegerstedt G., Maehle-Schmidt M., Nyrén O., Hammarström M. Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(6):497-503.
  16. Радзинский В.Е., Дурандин Ю.М., Гагаев Ч.Г., Токтар Л.Р., Марилова Н.А., Тотчиев Г.Ф., Шалаев О.Н. Перинеология: Болезни женской промежности в акушерско-гинекологических, сексологических, урологических, проктологических аспектах. Под редакцией В.Е. Радзинского. М., 2006; 336 с
  17. Schaffer J.I., Bloom S.L. A randomized trial of the effects of coached vs uncoached maternal pushing during the second stage of labor on postpartum pelvic floor structure and function. Am J Obstet Gynecol. 2005;192(5): 1692-1696
  18. Михальчук Н.С., Прудко А.Ю., Нечипоренко Н.А. Анатомическое и функциональное состояние мочевыводящих путей и почек у женщин с генитальным пролапсом. Журнал Гродненского государственного медицинского университета. 2012;4(40):46-49
  19. Lowder J.L., Frankman E.A., Ghetti C., Burrows L.J., Krohn M.A., Moalli P., Zyczynski H. Lower urinary tract symptoms in women with pelvic organ prolapse. Int Urogynecol J. 2010;21(6):665-672.
  20. Krissi H., Halperin R., Koren P., Peled Y. The presence and location of estrogen and progesterone receptors in the human pelvic cardinal ligaments. Pelviperineology. 2010;29:17-19.
  21. Progetto Menopausa Italia Study Group. Risk factors for genital prolapse in non-hysterectomized women around menopause: Results from a large crosssectional study in menopausal clinics in Italy. Eur J Obstet Gynecol Reprod Biol. 2000;93:135-140.
  22. Swift S., Woodman P., O’Boyle A., Kahn M., Valley M., Bland D., Wang W., Schaffer J. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;1929(3):795-806.
  23. Nygaard I, Barber M.D., Burgio K.L., Kenton K., Meikle S., Schaffer J., Spino C., Whitehead W.E., Wu J., Brody D.J.; Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311-1316.
  24. Chiaffarino F., Chatenoud L., Dindelli M., Meschia M., Buonaguidi A., Amicarelli F., Surace M., Bertola E., Di Cintio E., Parazzini F. Reproductive factors, family history, occupation and risk ofurogenital prolapse. Eur J Obstet Gynecol Reprod Biol. 1999;82(1):63-67.
  25. Sharma S., Walia I., Singh A. A case control study on uterine prolapse in a Chandigarh slum. Bull Postgrad Inst Med Educ Res Chandigarh. 2003;37:143-148.
  26. Jack G.S., Nikolova G., Vilain E., Raz S., Rodriguez L.V. Familial transmission of genitovaginal prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(5):498-501.
  27. Hannestad Y.S., Rortveit G., Daltveit A.K., Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003;110:247-254.
  28. McLennan M.T., Harris J.K., Kariuki B., Meyer S. Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1063-1069.
  29. Miedel A., Tegerstedt G., Maehle-Schmidt M., Nyrén O, Hammarström M. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol. 2009;113(5):1089-1097.
  30. Rodrigues A.M., Oliveira L.M., Martins Kde F., Del Roy C.A., Sartori M.G., Girao M.J., Castro Rde A. Risk factors for genital prolapse in a Brazilian population. Rev Bras Ginecol Obstet. 2009;31(1):17-21.
  31. Slieker-ten Hove M.C., Pool-Goudzwaard A.L., Eijkemans M.J., Steegers-Theunissen R.P., Burger C.W., Vierhout M.E. Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol. 2009;200(2):184 e1-7.
  32. Altman D., Forsman M., Falconer C., Lichtenstein P. Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol. 2008;54(4):918-22.
  33. Lince S.L., van Kempen L.C., Vierhout M.E., Kluivers K.B. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J. 2012;23(10):1327-1336.
  34. Mothes A.R., Radosa M.P., Altendorf-Hofmann A., Runnebaum I.B. Risk index for pelvic organ prolapse based on established individual risk factors. Arch Gynecol Obstet. 2016;293(3):617-624.
  35. Буянова С.Н., Савельев С.В., Федоров А.А. Роль ДСТвпатогенезе пролапса гениталий. Российский вестник акушера-гинеколога. Спецвыпуск. 2008. C. 8-11
  36. Kluivers K.B., Dijkstra J.R., Hendriks J.C., Lince S.L., Vierhout M.E., van Kempen L.C. COL3A1 2209G>A is a predictor of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1113-1118
  37. Сухих Г.Т., Данилов А.Ю., Боташева Д.А. Роль иммуногистохимических и генетических факторов в уточнении этиологии и патогенеза пролапса гениталий у женщин. Российский вестник акушера-гинеколога. 2012;2:47-50
  38. Нафтулович Р.А., Ящук А.Г., Алакаева Д.Р., Хусаинова Р.И. Значение наследственных факторов в возникновении пролапса тазовых органов. Российский вестник акушера-гинеколога. 2014;1:22-26
  39. Carley M.E., Schaffer J. Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos syndrome. Am J Obstet Gynec. 2000;182(5):1021-1023.
  40. Paladini D., Di Spiezio Sardo A., Mandato V.D., Guerra G., Bifulco G., Mauriello S., Nappi C. Association of cutis laxa and genital prolapse: a case report. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(11):1367-1370.
  41. Нафтулович Р.А., Ящук А.Г., Масленников А.В., Алакаева Д.Р. Особенности семейного анамнеза у пациенток с опущением и выпадением органов малого таза. Российский вестник акушера-гинеколога. 2013;1:30-36
  42. Salter S.A., Batra R.S., Rohrer T.E., Kohli N., Kimball A.B. Striae and pelvic relaxation: two disorders of connective tissue with a strong association. J Invest Dermatol. 2006;126:1745-1748.
  43. Lammers K., Lince S.L., Spath M.A., van Kempen L.C., Hendriks J.C., Vierhout M.E., Kluivers K.B. Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J. 2012;23:313-319.
  44. Lee S.W., Cho H.H., Kim M.R., You Y.O., Kim S.Y., Hwang Y.B., Kim J.H. Association between pelvic organ prolapse and bone mineral density in postmenopausal women. J Obstet Gynaecol. 2015;35(5):476-480.
  45. Veit-Rubin N., Cartwright R., Singh A.U., Digesu G.A., Fernando R., Khullar V. Association between joint hypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis. Int Urogynecol J. 2015. [Epub ahead of print].
  46. http://www.cdc.gov/genomics/hugenet/hugenavigator.htm
  47. Jackson S.R., Avery N.C., Tarlton J.F., Eckford S.D., Abrams P., Bailey A.J. Changes in metabolism of collagen in genitourinary prolapse. Lancet. 1996;347(9016):1658-1661.
  48. Фадеев А.С., Левачев С.М., Измайлова В.Н. Мономолекулярные слои коллагена. Вестник Московского университета. Серия 2: Химия. 1999;40(4):270-275
  49. Lim V.F., Khoo J.K., Wong V., Moore K.H. Recent studies of genetic dysfunction in pelvic organ prolapse: the role of collagen defects. Aust N Z J Obstet Gynaecol. 2014;54(3):198-205.
  50. Mann V., Hobson E.E., Li B., Stewart T.L., Grant S.F., Robins S.P., Aspden R.M., Ralston S.H. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest. 2001;107(7):899-907.
  51. Ward R.M., Velez Edwards D.R., Edwards T., Giri A., Jerome R.N., Wu J.M. Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol. 2014;211(4):326-335.
  52. Cartwright R.,Kirby A.C., Tikkinen K.A., Mangera A., Thiagamoorthy G., Rajan P., Pesonen J.S., Ambrose C., Gonzalez-Maffe J., Bennett P., Palmer T., Walley A., Järvelin M.R., Chapple C., Khullar V. Systematic review and meta-analysis of genetic association studies of urinary symptoms and prolapse in women. Am J Obstet Gynecol. 2015;212(2):199.e1-199.e24.
  53. Хаджиева М.Б., Камоева С.В., Иванова А.В., Абилев С.К., Сальникова Л.Е. Полиморфизм генов, контролирующих процессы эластогенеза, и риск развития пролапса тазовых органов у женщин. Генетика. 2015;51(10):1191-1198
  54. Liang C.C., Huang H.Y., Tseng L.H. et al. Expression of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 (TIMP-1, TIMP-2 and TIMP-3) in women with uterine prolapse but without urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2010;153:94-98.
  55. Budatha M., Roshanravan S., Zheng Q., Weislander C., Chapman S.L., Davis E.C., Starcher B., Word R.A., Yanagisawa H. Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans. J Clin Invest. 2011;121:2048-2059.
  56. Dviri M., Leron E., Dreiher J., Mazor M., Shaco-Levy R. Increased matrix metalloproteinases-1, -9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2011;156:113-117.
  57. Alarab M., Kufaishi H., Lye S., Drutz H., Shynlova O. Expression of extracellular matrix-remodeling proteins is altered in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Reprod Sci. 2014;21(6):704-715.
  58. Wang X., Li Y., Chen J., Guo X., Guan H., Li C. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse. Mol Med Rep. 2014;10(4):2004-2008.
  59. Skorupski P., Jankiewicz K., Miotia P., Marczak M., Kulik-Rechberger B., Rechberger T. The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse. Int Urogynecol J. 2013;24(6):1033-1038.
  60. Chen C., Hill L.D., Schubert C.M., Strauss J.F. 3rd, Matthews C.A. Is laminin gamma-1 a candidate gene for advanced pelvic organ prolapse? Am J Obstet Gynecol. 2010;202(5):505.e1-5.
  61. Nikolova G., Lee H., Berkovitz S., Nelson S., Sinsheimer J., Vilain E., Rodnguez L.V. Sequence variant in the laminin gamma1 (LAMC1) gene associated with familial pelvic organ prolapse. Hum Genet. 2007;120(6):847-856.
  62. Wu J.M., Visco A.G., Grass E.A., Craig D.M., Fulton R.G., Haynes C., Weidner A.C., Shah S.H. Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse. Obstet Gynecol. 2012;120(3):587-593.
  63. Jepsen K.J., Wu F., Peragallo J.H., Paul J., Roberts L., Ezura Y., Oldberg A., Birk D.E., Chakravarti S. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J. Biol. Chem. 2002; 277 (38): 3553-35540.
  64. Söderberg M.W., Byström B., Kalamajski S., Malmström A., Ekman-Ordeberg G. Gene expressions of small leucine-rich repeat proteoglycans and fibulin-5 are decreased in pelvic organ prolapse. Mol. Hum. Reprod. 2009;15 (4):251-257.
  65. Chen H.Y., Chung Y.W., Lin W.Y., Chen W.C., Tsai F.J., Tsai C.H. Estrogen receptor alpha polymorphism is associated with pelvic organ prolapse risk. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1159-1163.
  66. Chen H.Y., Chung Y.W., Lin W.Y., Chen W.C., Tsai F.J., Tsai C.H. Progesterone receptor polymorphism is associated with pelvic organ prolapse risk. Acta Obstet Gynecol Scand. 2009;88(7):835-838.
  67. Chen H.Y., Wan L., Chung Y.W., Chen W.C., Tsai F.J., Tsai C.H. Estrogen receptor beta gene haplotype is associated with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2008;138:105-109.
  68. Ли Е.С., Каппушева Л.М., Караева К.Ю. Результаты оперативного лечения генитального пролапса. Значение полиморфизмов генов коллагена III типа и рецептора эстрогена альфа. Доктор. Ру. Гинекология Эндокринология. 2015;11 (112):29-34
  69. Камоева С.В., Савченко Т.Н., Иванова А.В., Абаева Х.А. Современные генетические аспекты пролапса тазовых органов у женщин. Акушерство, гинекология и репродукция. 2013;7(1):17-21
  70. Drewes P.G., Yanagisawa H., Starcher B., Hornstra I., Csiszar K., Marinis S.I., Keller P., Word R.A. Pelvic organ prolapse in Fibulin-5 knockout mice: pregnancy changes in elastic fiber homeostasis in mouse vagina. Am J Pathol. 2007;170(2):578-589.
  71. Liu X., Zhao Y., Pawlyk B., Damaser M., Li T. Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am J Pathol. 2006;168(2): 519-528.
  72. Yamamoto K., Yamamoto M., Akazawa K., Tajima S., Wakimoto H., Aoyagi M. Decrease in elastin gene expression and protein synthesis in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol Int. 1997;21:605-611.
  73. Karam J.A., Vazquez D.V., Lin V.K., Zimmern P.E. Elastin expression and elastic fibre width in the anterior vaginal wall of postmenopausal women with and without prolapse. BJU Int. 2007;100(2):346-350.
  74. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y., Tashiro K., Ross Jr J., Honjo T., Chien K.R. Fibulin-5/ DANCE is essential for elastogenesis in vivo. Nature. 2002;10;415(6868):171-175.
  75. Klutke J., Ji Q., Campeau J., Starcher B., Carlos Felix J., Stanczyk F.Z., Klutke C. Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstetricia et Gynecologica. 2008;87:111-115.
  76. Northington G.M. Fibulin-5: two for the price of one maintaining pelvic support. J Clin Invest. 2011;121(5):2048-2059.
  77. Zhao B.H., Zhou J.H. Decreased expression of elastin, fibulin-5 and lysyl oxidase-like 1 in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse. J Obstet Gynaecol Res. 2012;38:925-931.
  78. Zhou Y., Ling O., Bo L. Expression and significance of lysyl oxidase-like 1 and fibulin-5 in the cardinal ligament tissue of patients with pelvic floor dysfunction. J Biomed Res. 2013;27:23-28.
  79. Wieslander C.K., Rahn D.D., McIntire D.D., Acevedo J.F., Drewes P.G., Yanagisawa H., Word R.A. Quantification of Pelvic Organ Prolapse in Mice: Vaginal Protease Activity Precedes Increased MOPQ Scores in Fibulin 5 Knockout Mice. Biol Reprod. 2009;80(3):407-414.
  80. Ji Q.S., Qi B., Wen Y.C. et al. The association of LOXL1 polymorphisms with exfoliation syndrome/glaucoma: Meta-analysis. Int J Ophthalmol. 2015;8(1):148-156.
  81. Liu X., Zhao Y., Gao J., Pawlyk B., Starcher B., Spencer J.A., Yanagisawa H., Zuo J., Li T. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36(2):178-182.
  82. Ferrell G., Lu M., Stoddard P. A single nucleotide polymorphism in the promoter of the LOXL1 gene and its relationship to pelvic organ prolapse and preterm premature rupture of membranes. REPROD SCI. 2009;16(5):438-446.
  83. Chen H.Y., Lu Y., Qi Y., Bai W.P., Liao Q.P. Relationship between the expressions of mitofusin-2 and procollagen in uterosacral ligament fibroblasts of postmenopausal patients with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2014;174:141-145.
  84. Kim E.J., Chung N., Park S.H., Lee K.H., Kim S.W., Kim J.Y., Bai S.W, Jeon M.J. Involvement of oxidative stress and mitochondrial apoptosis in the pathogenesis of pelvic organ prolapse. J Urol. 2013;189(2):588-594.
  85. Kim J.Y., Kim E.J., Jeon M.J., Kim R., Lee M.W., Kim S.W. Association between susceptibility to advanced pelvic organ prolapse and glutathione S-transferase P1 Ile105Val polymorphism. Eur J Obstet Gynecol Reprod Biol. 2014;175:205-208.
  86. Allen-Brady K., Cannon-Albright L., Farnham J.M., Teerlink C., Vierhout M.E., van Kempen L.C., Kluivers K.B., Norton P.A. Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol. 2011;118(6):1345-1353.
  87. Allen-Brady K., Norton P.A., Farnham J.M., Teerlink C., Cannon-Albright L.A. Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet. 2009;84(5):678-682.
  88. Giri A., Wu J.M., Ward R.M., Hartmann K.E., Park A.J., North K.E., Graff M., Wallace R.B., Bareh G., Qi L., O’Sullivan M.J., Reiner A.P., Edwards T.L., Velez Edwards D.R. Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women’s Health Initiative. PLoS One. 2015;10(11):e0141647.
  89. Rao S., Lang J., Zhu L., Chen J. Exome Sequencing Identifies a Novel Gene, WNK1, for Susceptibility to Pelvic Organ Prolapse (POP). PLoS One. 2015;10(3):e0119482.
  90. Wang Z., Shi H.H., Chen G., Zhu L. Role of canonical Wnt signaling transduction pathway in the pathogenesis of pelvic organ prolapse. Zhonghua Yi Xue Za Zhi. 2012;92(24):1669-1673.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies